We're loading the full news article for you. This includes the article content, images, author information, and related articles.
Africa’s largest medical manufacturer eyes a strategic 20-acre hub in Mombasa to supercharge exports and secure continental health security.

The simmering potential of Kenya’s industrial sector has ended in a decisive expansion. In a masterclass of strategic foresight and ambition, Revital Healthcare is moving to annihilate logistical barriers by eyeing the Dongo Kundu Special Economic Zone, effectively rewriting the region’s manufacturing history books in Mombasa.
This move is not merely an expansion; it is a statement of absolute industrial hegemony. By seeking an additional 20 acres at the coveted zone, the Kilifi-based manufacturer has signaled its intent to draw level with global pharmaceutical giants. The result leaves other local competitors gazing across a widening chasm of capacity, resources, and technical expertise that seems impossible to bridge without similar bold investments.
The announcement was billed as a routine update, but it unfolded as a methodical dismantling of the country’s reliance on imported medical devices. From the moment Director of Sales Roneek Vora took the podium, the company’s offensive strategy was clear. The facility already boasts a production capacity of two billion devices, but the new site aims to triple this output.
Indian High Commissioner Adarsh Swaika was the architect of the diplomatic support, touring the facility with a keen eye that left no doubt about the geopolitical significance of this venture. Beside him, SEZA CEO Kenneth Chelule orchestrated the regulatory assurances, dismantling bureaucratic hurdles piece by piece. "We didn’t just want to build a factory; we wanted to build a legacy," Vora was overheard saying. "This is the era of African self-reliance."
The Dongo Kundu SEZ has been lauded as a triumph of planning, cementing Mombasa’s reputation as East Africa’s premier logistics hub. Yet, for the local residents, the project is a stark reminder of the opportunities ahead. While the government provides the land, companies like Revital are writing the script of prosperity.
As the Revital team returns to the drawing board to finalize the designs, the question for the rest of the continent is no longer how to catch up, but how to partner with them to stop relying on foreign aid. For now, Revital sits alone on the throne of medical manufacturing in the region, unbeaten, untroubled, and undeniably superior.
The collaboration with Indian manufacturers is particularly strategic. India is often described as the pharmacy of the world, and by tapping into this expertise, Revital is effectively downloading decades of operational knowledge. This technology transfer is the secret weapon that will allow the Kenyan firm to produce value-added products that were previously the domain of European firms.
Ultimately, this expansion is about saving lives. With the capacity to produce billions of syringes and other critical devices, Kenya is positioning itself as the guardian of health security for Sub-Saharan Africa. When the next pandemic hits, the shield that protects the continent will likely bear the stamp "Made in Mombasa".
Keep the conversation in one place—threads here stay linked to the story and in the forums.
Sign in to start a discussion
Start a conversation about this story and keep it linked here.
Other hot threads
E-sports and Gaming Community in Kenya
Active 9 months ago
The Role of Technology in Modern Agriculture (AgriTech)
Active 9 months ago
Popular Recreational Activities Across Counties
Active 9 months ago
Investing in Youth Sports Development Programs
Active 9 months ago